Allogene Therapeutics ALLO
NASDAQ ALLO
$1.33 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Other financing activities (2024 - 2025)

Updated

Allogene Therapeutics (ALLO) reported Other financing activities of $6.91 million for FY2025, up 203.0% from $2.28 million in FY2024.

Analysis

Allogene Therapeutics (ALLO) Other financing activities (2024 - 2025) Analysis & Trends

  • According to Business Quant data, Other financing activities came in at $2.28 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Allogene Therapeutics 435.17 Mn -666.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.56 Mn
Mar 31, 2025 3.35 Mn
Jun 30, 2024 2.28 Mn
API Access

Allogene Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ALLO&period=max&api_key=YOUR_API_KEY